Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Preferred Dividends : HK$0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Shenzhen Neptunus Interlong Bio-Technique Co Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Shenzhen Neptunus Interlong Bio-Technique Co's preferred dividends for the three months ended in Jun. 2024 was HK$0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0 Mil.

Shenzhen Neptunus Interlong Bio-Technique Co Preferred Dividends Historical Data

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Neptunus Interlong Bio-Technique Co Preferred Dividends Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Get a 7-Day Free Trial

Shenzhen Neptunus Interlong Bio-Technique Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Shenzhen Neptunus Interlong Bio-Technique Co Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.

Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) » Definitions » Preferred Dividends

Traded in Other Exchanges

N/A

Address

95 Queensway, 18th Floor, United Centre, Admiralty, Hong Kong, HKG

Website

https://www.interlong.com

Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sales of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines; and the Sales and distribution of medicines and healthcare products. The majority of revenue is generated from the Manufacturing and selling of medicines.

Shenzhen Neptunus Interlong Bio-Technique Co Headlines

No Headlines